Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia, Myeloid, Acute 16Burkitt Lymphoma 15Leukemia, Myeloid, Accelerated Phase 10Blast Crisis 10Lymphoma, Mantle-Cell 8Congenital Abnormalities 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 7Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 7Hematologic Neoplasms 7Primary Myelofibrosis 6Myeloproliferative Disorders 6Multiple Myeloma 6Myelodysplastic Syndromes 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Biphenotypic, Acute 4Sezary Syndrome 3Recurrence 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Immunoblastic 3Breast Neoplasms 3Waldenstrom Macroglobulinemia 2

Interventions

Gemcitabine 87Cisplatin 66Cystectomy 38pembrolizumab 34Docetaxel 25Nivolumab 24durvalumab 21Paclitaxel 19Magnetic Resonance Spectroscopy 18Radiotherapy 17Mitomycin 17Carboplatin 16atezolizumab 15Doxorubicin 14Cystoscopy 14BCG Vaccine 13Surveys and Questionnaires 12Standard of Care 12avelumab 11Sunitinib 10tremelimumab 9Transurethral Resection of Bladder 9Ipilimumab 9Filgrastim 9Blood Specimen Collection 9Specimen Handling 8Neoadjuvant Therapy 8Methotrexate 8Methods 8Early Intervention, Educational 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Urinary Bladder Neoplasms × merphos × Clear all
NCT04383743 2025-09-18

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

University of Washington

Phase 2 Completed
17 enrolled 12 charts
Genitourinary

Urinary Bladder Neoplasms

NCT01639521 2014-01-29

Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer

University of Southern California

Phase 2 Withdrawn
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡